Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication

By Yahoo! Finance | Oct 3, 2024 at 10:20 AM EST

PGIM Jennison Health Sciences Fund's Q2 2024 investor letter discussed stock performance, highlighting Amgen Inc. (NASDAQ:AMGN). The fund noted Amgen's one-month return and market capitalization. They mentioned the potential of AI stocks for higher returns compared to Amgen.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.